The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended Moderna's COVID-19 vaccine Spikevax for use in the vaccination of children aged six to 11 in the European Union (EU) on Thursday, Feb. 24. Spikevax is now awaiting conditional marketing...